Cerenion awarded trademarks on C-Trend® in Europe and the USA

The European Union Intellectual Property Office (EUIPO) and the U.S. Patent and Trademark Office (USPTO) have separately awarded Cerenion Oy trademarks on its upcoming C-Trend® technology.
"The new trademarks provide protection for the novel intellectual property associated with our next-generation brain monitoring technology as we approach market launch", reports Dr. Timo Koskela, CEO of Cerenion.
The path to protecting intellectual property via trademarks and patents is often long as it may take years to process applications.
"The origins of our technology lie in several years of research at the University of Oulu in Finland and we are only now beginning to see the first patents come through", says Dr. Jukka Kortelainen, Chief Medical Officer and head of IPR Management at Cerenion. "We have filed multiple intellectual property applications on our technology worldwide, and expect to obtain at least three patents later this year", continues Dr. Koskela.
Visit us
Contact us
Cerenion Oy has received support from the European Regional Development Fund of the European Union.
Cerenion Oy
Elektroniikkatie 3
90590 Oulu
Cerenion Oy
Firdonkatu 2 T 63
00520 Helsinki
Call us: +358 50 447 4909
E-mail us:
This website and all of the content therein is for reference purposes only and is not intended to substitute for advice from a licensed healthcare professional. Not available in the United States. Cerenion™, Cerenion C-Trend™, C-Trend™, "The next-generation brain monitoring company"™ and "The pulse of the brain"™ are registered trademarks and/or trademarks of Cerenion Oy. Cerenion C-Trend™ is intended for use by qualified medical practitioners who will exercise professional judgment in its use. Cerenion technology is protected by Intellectual Property Rights. Patents pending worldwide. All rights reserved. © Cerenion Oy 2020.
Powered by:MetaVisual CMSMobile versionDesktop versionLog in© 2017 - 2021 Cerenion Oy